Salbutamol Sulfate



Indications and Reactions:

Role Indications Reactions
Primary
Asthma 44.4%
Multiple Allergies 33.3%
Hypersensitivity 11.1%
Status Asthmaticus 11.1%
Troponin Increased 25.0%
Drug Hypersensitivity 12.5%
Dyspnoea 12.5%
Pharmaceutical Product Complaint 12.5%
Pulmonary Haemorrhage 12.5%
Stress Cardiomyopathy 12.5%
Vision Blurred 12.5%
Secondary
Asthma 36.0%
Product Used For Unknown Indication 9.9%
Drug Use For Unknown Indication 7.2%
Chronic Obstructive Pulmonary Disease 6.3%
Anxiety 4.5%
Osteoporosis 3.6%
Panic Attack 3.6%
Arthralgia 2.7%
Back Pain 2.7%
Depression 2.7%
Gastrooesophageal Reflux Disease 2.7%
Musculoskeletal Pain 2.7%
Pain In Extremity 2.7%
Acute Sinusitis 1.8%
Bronchitis Acute 1.8%
Hypertension 1.8%
Hypothyroidism 1.8%
Osteoarthritis 1.8%
Post-traumatic Stress Disorder 1.8%
Synovial Cyst 1.8%
White Blood Cell Count Increased 11.1%
Drug Interaction 7.4%
Epidural Lipomatosis 7.4%
Lower Respiratory Tract Infection 7.4%
Pain 7.4%
Vanishing Twin Syndrome 7.4%
Back Pain 3.7%
Death 3.7%
Drug Ineffective 3.7%
Exposure During Pregnancy 3.7%
Feeling Abnormal 3.7%
Hyperhidrosis 3.7%
Hypermetropia 3.7%
Leukocytoclastic Vasculitis 3.7%
Oropharyngeal Pain 3.7%
Pruritus 3.7%
Rash Erythematous 3.7%
Scab 3.7%
Stress Cardiomyopathy 3.7%
Tremor 3.7%
Concomitant
Drug Use For Unknown Indication 25.8%
Asthma 13.2%
Product Used For Unknown Indication 12.5%
Rheumatoid Arthritis 7.8%
Pain 5.4%
Chronic Obstructive Pulmonary Disease 4.6%
Hypertension 3.9%
Bronchopulmonary Dysplasia 2.5%
Crohn's Disease 2.5%
Non-small Cell Lung Cancer 2.4%
Osteoarthritis 2.3%
Depression 2.2%
Hiv Infection 2.2%
Smoking Cessation Therapy 2.1%
Bronchitis 2.0%
Diabetes Mellitus 2.0%
Hypersensitivity 1.9%
Pneumonia 1.9%
Gastrooesophageal Reflux Disease 1.6%
Prophylaxis 1.5%
Pneumonia 10.9%
Urinary Tract Infection 7.0%
Weight Increased 7.0%
Accidental Exposure 6.3%
Respiratory Failure 6.3%
Vomiting 6.3%
Weight Decreased 5.5%
White Blood Cell Count Increased 5.5%
Sinusitis 4.7%
Vasculitis 4.7%
Ventricular Fibrillation 4.7%
Myocardial Infarction 3.9%
Shock 3.9%
Syncope 3.9%
Tremor 3.9%
Death 3.1%
Incorrect Dose Administered 3.1%
Malaise 3.1%
Pain 3.1%
Pyrexia 3.1%
Interacting
Asthma 71.4%
Smoking Cessation Therapy 28.6%
Drug Interaction 100.0%